Table 3 Drug susceptibility analysis according to IGFBP6
From: Lysine lactylation (Kla) might be a novel therapeutic target for breast cancer
Drug | cor | pvalue | Drug | cor | pvalue |
|---|---|---|---|---|---|
Midostaurin | 0.3823 | 0.0026 | Tyrothricin | -0.2775 | 0.0318 |
Bleomycin | 0.3698 | 0.0036 | Dolastatin 10 | -0.2817 | 0.0292 |
Staurosporine | 0.3524 | 0.0058 | Cyclophosphamide | -0.2867 | 0.0264 |
Dasatinib | 0.3448 | 0.0070 | Hypothemycin | -0.3047 | 0.0179 |
Floxuridine | 0.3374 | 0.0084 | Lapachone | -0.3080 | 0.0167 |
Simvastatin | 0.3141 | 0.0145 | Actinomycin D | -0.3160 | 0.0139 |
Irofulven | 0.2921 | 0.0236 | Tamoxifen | -0.3222 | 0.0121 |
Ibrutinib | 0.2810 | 0.0296 | Eribulin mesilate | -0.3315 | 0.0097 |
5-fluoro deoxy uridine 10mer | 0.2740 | 0.0341 | Vinblastine | -0.3343 | 0.0090 |
Itraconazole | 0.2572 | 0.0472 | Nilotinib | -0.3514 | 0.0059 |
Imatinib | -0.2548 | 0.0494 | Vinorelbine | -0.3553 | 0.0053 |
Cobimetinib (isomer 1) | -0.2570 | 0.0474 | Bafetinib | -0.3693 | 0.0037 |
Raloxifene | -0.2578 | 0.0468 | Pipamperone | -0.3736 | 0.0033 |
Selumetinib | -0.2605 | 0.0444 | Arsenic trioxide | -0.3763 | 0.0030 |
Paclitaxel | -0.2664 | 0.0396 | Â | Â | Â |